Price T Rowe Associates Inc. MD Boosts Stake in Schrödinger, Inc. (NASDAQ:SDGR)

Price T Rowe Associates Inc. MD lifted its position in Schrödinger, Inc. (NASDAQ:SDGR) by 8.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 42,009 shares of the company’s stock after acquiring an additional 3,376 shares during the period. Price T Rowe Associates Inc. MD owned 0.06% of Schrödinger worth $811,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in SDGR. Paradigm Asset Management Co. LLC purchased a new stake in Schrödinger in the fourth quarter worth $50,000. GAMMA Investing LLC grew its position in shares of Schrödinger by 87.5% in the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company’s stock worth $54,000 after buying an additional 1,305 shares during the period. KBC Group NV increased its stake in shares of Schrödinger by 73.9% in the 4th quarter. KBC Group NV now owns 4,361 shares of the company’s stock worth $84,000 after acquiring an additional 1,853 shares in the last quarter. XTX Topco Ltd purchased a new position in Schrödinger during the 4th quarter valued at about $199,000. Finally, Proficio Capital Partners LLC bought a new stake in Schrödinger during the fourth quarter worth about $218,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

SDGR has been the subject of several recent research reports. Piper Sandler lowered their target price on shares of Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. KeyCorp increased their target price on Schrödinger from $30.00 to $32.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Schrödinger currently has an average rating of “Buy” and an average target price of $32.80.

Schrödinger Trading Up 0.1%

SDGR stock opened at $23.90 on Monday. The stock’s 50 day simple moving average is $22.62 and its 200 day simple moving average is $21.82. Schrödinger, Inc. has a 12-month low of $16.60 and a 12-month high of $28.47. The stock has a market capitalization of $1.75 billion, a PE ratio of -10.21 and a beta of 1.84.

Schrödinger (NASDAQ:SDGR) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing the consensus estimate of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The business had revenue of $59.55 million during the quarter, compared to analysts’ expectations of $54.60 million. During the same quarter in the prior year, the firm earned ($0.86) EPS. The firm’s revenue for the quarter was up 62.7% compared to the same quarter last year. On average, research analysts predict that Schrödinger, Inc. will post -2.37 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Karen Akinsanya sold 16,723 shares of the firm’s stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the transaction, the insider now directly owns 15,625 shares in the company, valued at $392,031.25. This trade represents a 51.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the sale, the chief financial officer now directly owns 27,544 shares of the company’s stock, valued at $599,357.44. The trade was a 16.62% decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is owned by insiders.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.